|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 14
Zeitschriftenartikel
Klausz, Katja; Kellner, Christian; Gehlert, Carina Lynn; Krohn, Steffen; Wilcken, Hauke; Floerkemeier, Inken; Günther, Andreas; Bauerschlag, Dirk O.; Clement, Bernd; Gramatzki, Martin und Peipp, Matthias
(2022):
The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In Vivo.
In: Molecular Cancer Therapeutics, Bd. 21, Nr. 1: S. 70-78
Behr, Jürgen; Günther, Andreas; Bonella, Francesco; Dinkel, Julien; Fink, Ludger; Geiser, Thomas; Geissler, Klaus; Glaser, Sven; Handzhiev, Sabin; Jonigk, Danny; Koschel, Dirk; Kreuter, Michael; Leuschner, Gabriela; Markart, Philipp; Prasse, Antje; Schönfeld, Nicolas; Schupp, Jonas Christian; Sitter, Helmut; Müller-Quernheim, Joachim und Costabel, Ulrich
(2021):
S2K Guideline for Diagnosis of Idiopathic Pulmonary Fibrosis.
In: Respiration, Bd. 100, Nr. 3: S. 238-270
Ota, Chiharu; Ng-Blichfeldt, John-Poul; Korfei, Martina; Alsafadi, Hani N.; Lehmann, Mareike; Skronska-Wasek, Wioletta; Santis, Martina M. de; Günther, Andreas; Wagner, Darcy E. und Königshoff, Melanie
(2018):
Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis.
In: Scientific Reports, Bd. 8, 12983
[PDF, 8MB]
Al-Tamari, Hamza M.; Dabral, Swati; Schmall, Anja; Sarvari, Pouya; Ruppert, Clemens; Paik, Jihye; DePinho, Ronald A.; Grimminger, Friedrich; Eickelberg, Oliver; Günther, Andreas; Seeger, Werner; Savai, Rajkumar und Pullamsetti, Soni S.
(2018):
FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.
In: EMBO Molecular Medicine, Bd. 10, Nr. 2: S. 276-293
Hengst, Meike; Naehrlich, Lutz; Mahavadi, Poornima; Grosse-Onnebrink, Jörg; Terheggen-Lagro, Suzanne; Skanke, Lars Hosoien; Schuch, Luise A.; Brasch, Frank; Günther, Andreas; Reu, Simone; Ley-Zaporozhan, Julia und Griese, Matthias
(2018):
Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood.
In: Orphanet Journal of Rare Diseases
13:42
[PDF, 2MB]
Behr, Jürgen; Günther, Andreas; Bonella, Francesco; Geissler, Klaus; Koschel, Dirk; Kreuter, Michael; Prasse, Antje; Schönfeld, Nicolas; Sitter, Helmut; Müller-Quernheim, Joachim und Costabel, Ulrich
(2018):
German Guideline for Idiopathic Pulmonary Fibrosis – Update on Pharmacological Therapies 2017.
In: Pneumologie, Bd. 72, Nr. 2: S. 155-168
Mümmler, Carlo; Burgy, Olivier; Hermann, Sarah; Mutze, Kathrin; Günther, Andreas und Königshoff, Melanie
(2018):
Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
In: FASEB Journal, Bd. 32, Nr. 2: S. 703-716
Martin-Medina, Aina; Lehmann, Mareike; Burgy, Olivier; Hermann, Sarah; Baarsma, Hoeke A.; Wagner, Darcy E.; De Santis, Martina M.; Ciolek, Florian; Hofer, Thomas P.; Frankenberger, Marion; Aichler, Michaela; Lindner, Michael; Gesierich, Wolfgang; Günther, Andreas; Walch, Axel; Coughlan, Christina; Wolters, Paul; Lee, Joyce S.; Behr, Jürgen und Königshoff, Melanie
(2018):
Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis.
In: American Journal of Respiratory and Critical Care Medicine, Bd. 198, Nr. 12: S. 1527-1538
Behr, Jürgen; Neuser, Petra; Prasse, Antje; Kreuter, Michael; Rabe, Klaus; Schade-Brittinger, Carmen; Wagner, Jasmin und Günther, Andreas
(2017):
Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.
In: BMC Pulmonary Medicine
17:122
[PDF, 358kB]
Behr, Jürgen; Günther, Andreas; Bonella, Francesco; Geißler, Klaus; Koschel, Dirk; Kreuter, Michael; Prasse, Antje; Schönfeld, Nicolas; Sitter, Helmut; Müller-Quernheim, Joachim und Costabel, Ulrich
(2017):
S2k-Leitlinie Idiopathische Lungenfibrose – Update zur medikamentösen Therapie 2017.
In: Pneumologie, Bd. 71, Nr. 7: S. 460-474
Lehmann, Mareike; Korfei, Martina; Mutze, Kathrin; Klee, Stephan; Skronska-Wasek, Wioletta; Alsafadi, Hani N.; Ota, Chiharu; Costa, Rita; Schiller, Herbert B.; Lindner, Michael; Wagner, Darcy E.; Günther, Andreas und Koenigshoff, Melanie
(2017):
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo.
In: European Respiratory Journal, Bd. 50, Nr. 2, 1602367
Behr, Jürgen; Bendstrup, Elisabeth; Crestani, Bruno; Günther, Andreas; Olschewski, Horst; Sköld, C. Magnus; Wells, Athol; Wuyts, Wim; Koschel, Dirk; Kreuter, Michael; Wallaert, Benoit; Lin, Chin-Yu; Beck, Jürgen und Albera, Carlo
(2016):
Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
In: Lancet Respiratory Medicine, Bd. 4, Nr. 6: S. 445-453
Günther, Andreas; Baumann, Philipp; Burger, Renate; Kellner, Christian; Klapper, Wolfram; Schmidmaier, Ralf und Gramatzki, Martin
(2015):
Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study.
In: Haematologica, Bd. 100, Nr. 4: S. 544-550
[PDF, 372kB]
Kreuter, Michael; Herth, Felix J. F.; Wacker, Margarethe; Leidl, Reiner 
ORCID: https://orcid.org/0000-0002-7115-7510; Hellmann, Andreas; Pfeifer, Michael; Behr, Jürgen; Witt, Sabine; Kauschka, Dagmar; Mall, Marcus; Günther, Andreas und Markart, Philipp
(2015):
Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry-The EXCITING-ILD Registry.
In: Biomed Research International, 123876
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-7115-7510; Hellmann, Andreas; Pfeifer, Michael; Behr, Jürgen; Witt, Sabine; Kauschka, Dagmar; Mall, Marcus; Günther, Andreas und Markart, Philipp
(2015):
Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry-The EXCITING-ILD Registry.
In: Biomed Research International, 123876
[PDF, 1MB]